Can individuals with bipolar disorder achieve and maintain a stable, normal mood?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Bipolar Patients Achieve a Normal Mood?

Yes, individuals with bipolar disorder can achieve and maintain stable, normal mood (euthymia), but this requires long-term maintenance treatment with mood stabilizers for at least 2 years after the last episode, combined with psychosocial interventions. 1

The Reality of Mood Stabilization

The evidence clearly demonstrates that bipolar disorder is a chronic, recurrent condition where achieving sustained mood stability is possible but requires ongoing treatment. The WHO guidelines explicitly recommend that maintenance treatment with lithium or valproate should continue for at least 2 years after the last episode of bipolar disorder, with decisions about continuation beyond 2 years made by a mental health specialist 1. This indicates that "normal mood" is achievable, but it's not a cure—it's an actively maintained state.

Key Treatment Framework

For acute mania:

  • First-line options include lithium, valproate, carbamazepine, or haloperidol 1
  • Second-generation antipsychotics (aripiprazole, olanzapine, risperidone, quetiapine) are alternatives 2

For maintenance (preventing relapse):

  • Lithium or valproate are the cornerstone treatments 1
  • Lamotrigine and olanzapine also have FDA approval for maintenance in adults 2

For bipolar depression:

  • Antidepressants (SSRIs like fluoxetine) may be used, but always in combination with a mood stabilizer (never as monotherapy) 1
  • The combination of olanzapine and fluoxetine is FDA-approved for bipolar depression 2

The Challenge: Mood Instability vs. Mood Stability

Recent research reveals that approximately 50-52% of individuals with bipolar disorder experience moderate mood instability, and 9-10% experience high mood instability even during treatment 3. This mood variability—measured as week-to-week fluctuations—is a major source of morbidity and significantly predicts worse functional outcomes 3, 4, 5.

The critical insight is that approximately 75% of symptomatic time in bipolar disorder consists of depressive episodes or symptoms 6, making depression—not mania—the primary barrier to sustained normal mood. This is why maintenance treatment focuses heavily on preventing both poles of the illness.

Essential Psychosocial Components

Psychoeducation should be routinely offered to individuals with bipolar disorder and their families 1. This is not optional—it's a core component of achieving mood stability. Additional interventions include:

  • Cognitive behavioral therapy and family interventions when trained professionals are available 1
  • Psychosocial interventions to enhance independent living and social skills 1
  • Supported employment and housing as needed 1

Critical Pitfalls to Avoid

  1. Premature discontinuation of medication: Even when patients feel stable for years, withdrawal carries increased relapse risk and should only be considered in consultation with a mental health professional 1

  2. Antidepressant monotherapy: Using antidepressants without a mood stabilizer can destabilize mood or trigger manic episodes 2. This is a common and dangerous error.

  3. Focusing only on episode prevention: The evidence shows that even between episodes, many patients experience chronic mood instability that impairs functioning 3, 4. Treatment goals must address this ongoing variability, not just prevent full episodes.

  4. Poor medication adherence: More than 50% of patients with bipolar disorder are non-adherent to treatment 6, which directly undermines the ability to maintain normal mood.

Long-Term Prognosis

The sobering reality is that life expectancy is reduced by 12-14 years in people with bipolar disorder 6, with elevated rates of metabolic syndrome (37%), obesity (21%), smoking (45%), and type 2 diabetes (14%) 6. The annual suicide rate is approximately 0.9%, with 15-20% of individuals dying by suicide 6. These outcomes emphasize that achieving "normal mood" requires comprehensive, sustained treatment addressing both psychiatric and medical comorbidities.

Early diagnosis and treatment are associated with more favorable prognosis 6, yet diagnosis is often delayed by approximately 9 years following the initial depressive episode 6. This delay significantly impacts the ability to achieve and maintain mood stability.

Bottom Line

Normal mood is achievable in bipolar disorder, but it requires lifelong vigilance with pharmacotherapy (primarily lithium or valproate), psychosocial interventions, and close monitoring. The goal is sustained euthymia—a stable, normal mood state—rather than cure. Without maintenance treatment, relapse rates are high, and the chronic mood instability that characterizes this illness will persist, severely impacting quality of life and functioning.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.